May 29, 2019

Pere Santamaria explains how Navacims works

UCalgary scientist describes the precision nanomedicine treatment at the centre of new worldwide collaboration and licence agreement

On May 16, a scientist at the University of Calgary made headlines around the world, when a collaboration and licence agreement was announced for a precision nanomedicine he had discovered. In this video, Dr. Pere Santamaria, MD, PhD, explains how Navacims triggers a naturally occurring regulatory mechanism within the immune system to protect against autoimmune disease.

What happens when the body attacks itself?